Skip to main content
Premium Trial:

Request an Annual Quote

Roka's Extended On Board Stability for Atlas System

Roka Bioscience has launched the Extended On Board stability feature for the Atlas System. The new feature improves the stability of the Atlas kits from 4 days to 14 days, negating the prerequisite of high daily sample volumes in order to achieve maximum economic workflow efficiency, the company said.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.